Fusion Pharmaceuticals Inc. Restricted Cash, Noncurrent
Fusion Pharmaceuticals Inc. had Restricted Cash, Noncurrent of $849.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:RestrictedCashNoncurrent · last filed 2024-05-07
- 2024-03-31: Restricted Cash, Noncurrent $849.00K.
- 2023-12-31: Restricted Cash, Noncurrent $849.00K.
- 2023-09-30: Restricted Cash, Noncurrent $849.00K.
- 2023-06-30: Restricted Cash, Noncurrent $849.00K.
| Period end | Restricted Cash, Noncurrent |
|---|---|
| 2024-03-31 | $849.00K 10-Q · filed 2024-05-07 |
| 2023-12-31 | $849.00K 10-Q · filed 2024-05-07 |
| 2023-09-30 | $849.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $849.00K 10-Q · filed 2023-08-08 |
| 2023-03-31 | $849.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.02M 10-K · filed 2024-03-20 |
| 2022-09-30 | $1.02M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $1.02M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $1.02M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $1.22M 10-K · filed 2023-03-16 |
| 2021-09-30 | $1.22M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $1.22M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $1.22M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $1.47M 10-K · filed 2022-03-17 |
| 2020-09-30 | $1.47M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $1.50M 10-Q · filed 2020-08-11 |
| 2019-12-31 | $1.50M 10-K · filed 2021-03-25 |